Bonaventura Clotet to HIV Infections
This is a "connection" page, showing publications Bonaventura Clotet has written about HIV Infections.
Connection Strength
1.348
-
Efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in the treatment of HIV-1. Expert Opin Pharmacother. 2018 Jun; 19(8):929-934.
Score: 0.118
-
Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients. J Antimicrob Chemother. 2018 03 01; 73(3):732-737.
Score: 0.116
-
Aging in HIV-Infected Subjects: A New Scenario and a New View. Biomed Res Int. 2017; 2017:5897298.
Score: 0.114
-
Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries. Scand J Infect Dis. 2013 Aug; 45(8):635-44.
Score: 0.082
-
Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice. Br J Clin Pharmacol. 2007 Jun; 63(6):715-21.
Score: 0.054
-
Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study). J Acquir Immune Defic Syndr. 2005 Jan 01; 38(1):47-52.
Score: 0.047
-
Routine Screening of Anal Cytology in Persons With Human Immunodeficiency Virus and the Impact on Invasive Anal Cancer: A Prospective Cohort Study. Clin Infect Dis. 2020 07 11; 71(2):390-399.
Score: 0.034
-
NEU Screen Shows High Accuracy in Detecting Cognitive Impairment in Older Persons Living With HIV. J Assoc Nurses AIDS Care. 2019 Jan-Feb; 30(1):35-41.
Score: 0.031
-
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort. AIDS. 2018 10 23; 32(16):2405-2416.
Score: 0.030
-
Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies. Front Immunol. 2018; 9:2429.
Score: 0.030
-
Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant. Ann Intern Med. 2018 11 20; 169(10):674-683.
Score: 0.030
-
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study. Lancet HIV. 2018 11; 5(11):e638-e646.
Score: 0.030
-
High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs. J Antimicrob Chemother. 2018 09 01; 73(9):2452-2459.
Score: 0.030
-
Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up. Int J STD AIDS. 2019 01; 30(1):56-63.
Score: 0.030
-
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol. 2019 01; 12(1):232-246.
Score: 0.030
-
Effectiveness of physically ablative and pharmacological treatments for anal condyloma in HIV-infected men. PLoS One. 2018; 13(8):e0199033.
Score: 0.030
-
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir. Nat Commun. 2018 07 16; 9(1):2739.
Score: 0.030
-
High Prevalence of Sarcopenia in HIV-Infected Individuals. Biomed Res Int. 2018; 2018:5074923.
Score: 0.030
-
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial. J Antimicrob Chemother. 2018 07 01; 73(7):1965-1971.
Score: 0.030
-
Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs. J Antimicrob Chemother. 2018 07 01; 73(7):1940-1948.
Score: 0.030
-
Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses. J Virol. 2018 06 15; 92(12).
Score: 0.029
-
Recurrent coronary disease in HIV-infected patients: role of drug-drug interactions. Br J Clin Pharmacol. 2018 07; 84(7):1617-1619.
Score: 0.029
-
Memory B cell dysregulation in HIV-1-infected individuals. AIDS. 2018 Jan 14; 32(2):149-160.
Score: 0.029
-
Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir. Antimicrob Agents Chemother. 2017 11; 61(11).
Score: 0.028
-
Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery. PLoS One. 2017; 12(9):e0184433.
Score: 0.028
-
Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery. Sci Rep. 2017 09 15; 7(1):11711.
Score: 0.028
-
Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study. PLoS One. 2017; 12(8):e0182547.
Score: 0.028
-
Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV-Coinfected Patients in Clinical Practice. J Ultrasound Med. 2018 Jan; 37(1):113-121.
Score: 0.028
-
Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial. J Antimicrob Chemother. 2015 Apr; 70(4):1139-45.
Score: 0.023
-
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis. 2014 Jul 21; 14:407.
Score: 0.023
-
Stable HIV-1 integrase diversity during initial HIV-1 RNA decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy. Virol J. 2013 Dec 05; 10:350.
Score: 0.022
-
Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment. Antivir Ther. 2010; 15(3):333-42.
Score: 0.016
-
On the steps of cell-to-cell HIV transmission between CD4 T cells. Retrovirology. 2009 Oct 13; 6:89.
Score: 0.016
-
Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks. J Acquir Immune Defic Syndr. 2005 Dec 01; 40(4):413-21.
Score: 0.012
-
Role of viral kinetics under HCV therapy in HIV/HCV-coinfected patients. J Antimicrob Chemother. 2005 Jun; 55(6):824-7.
Score: 0.012
-
[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)]. Enferm Infecc Microbiol Clin. 2004 Dec; 22(10):564-642.
Score: 0.012
-
RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages. Sci Rep. 2017 10 17; 7(1):13339.
Score: 0.007
-
Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors. Sci Rep. 2017 06 16; 7(1):3717.
Score: 0.007
-
SAMHD1 is active in cycling cells permissive to HIV-1 infection. Antiviral Res. 2017 06; 142:123-135.
Score: 0.007
-
[Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy]. Enferm Infecc Microbiol Clin. 2011 Dec; 29(10):721-30.
Score: 0.005
-
Genotypic and phenotypic evolution of HIV type-1 protease during in vitro sequential or concomitant combination of atazanavir and amprenavir. Antivir Ther. 2010; 15(3):431-6.
Score: 0.004